The ACCC announced that it would not oppose the proposed acquisition of Pfizer Nutrition from Pfizer Inc by Nestlé S.A. after accepting undertakings requiring Nestlé to license Pfizer Nutrition’s Australian infant nutrition business’ brand portfolio to an independent purchaser to be approved by the ACCC.